Patent application number | Description | Published |
20100279966 | COMPOSITIONS AND METHODS FOR TREATING CANCER - Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them. | 11-04-2010 |
20100279967 | COMPOSITIONS AND METHODS FOR TREATING CANCER - Provided herein are methods of treating cancer comprising administering decitabine in combination with compounds that inhibit the deamination enzyme responsible for the inactivation of decitabine. | 11-04-2010 |
20100279977 | COMPOSITIONS AND METHODS FOR TREATING CANCER - Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them. | 11-04-2010 |
20120289475 | Certain Compounds, Compositions and Methods - The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds. | 11-15-2012 |
20130116207 | Compositions and Methods for Treating Cancer - Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them. | 05-09-2013 |
20140186335 | Certain Compounds, Compositions and Methods - The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds. | 07-03-2014 |
20140221305 | Compositions and Methods for Treating Cancer - Provided herein are compounds used to inhibit the deamination enzyme responsible for the inactivation of therapeutic compounds, and methods of using them. | 08-07-2014 |
20150210730 | CERTAIN COMPOUNDS, COMPOSITIONS AND METHODS - The present invention provides certain tetrahydrouridine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of making and using such compounds. | 07-30-2015 |